-+ 0.00%
-+ 0.00%
-+ 0.00%

FibroBiologics wins US patent on fibroblast-assisted islet transplant engraftment for Type 1 diabetes

PUBT·08/11/2026 12:31:24
Listen to the news
FibroBiologics wins US patent on fibroblast-assisted islet transplant engraftment for Type 1 diabetes
  • FibroBiologics received U.S. Patent No. 12,691,147 covering use of fibroblasts to improve engraftment, survival, and function of transplanted insulin-producing islets.
  • The methods target early post-implant losses that limit islet transplant outcomes, aiming to boost long-term viability via improved microenvironment and vascular support.
  • The company said stronger engraftment could reduce donor islet requirements per patient, potentially expanding access amid limited donor pancreas supply.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608110830PR_NEWS_USPR_____DA23146) on August 11, 2026, and is solely responsible for the information contained therein.